Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
Microminer is focused on developing innovative and sustainable technologies for extracting and recycling critical metals,
Synuca Therapeutics focused on developing innovative therapies for neurological disorders, particularly Parkinson's disease.
Cambiotics mission is to reducing the widespread presence of chemicals in the body whc are spread through various everyday products.
HHC Medical is a health tech company developing targeted non-invasive drug delivery devices.
BOOST Pharma develops a stem cell therapy for the treatment of osteogenesis imperfecta.
MATR Foods is a food-tech startup that provides fungi-based food ingredients.
Rapidemic is a developer of diagnostic kits for infectious diseases.
Prenaital is an AI-driven healthcare company, to revolutionizing maternal care by improving detection & management of high-risk pregnancies.
Alea provides quick, easy, and safe quantum random number generators.
Pioneering Resilient Agriculture with Natural Biomolecules
Droplet IV here to create better patient outcomes and reduce the burden of nurses by building the futur of IV infusion therapy.
Ousia Pharma focuses on the design and development of pharmacotherapies to improve the health and lives of people living with obesity.
metaLead Therapeutics is to develop this peptide as a next-generation Pb poisoning treatment.
Agoprene develops furniture foam from seaweed - completely free of petrochemicals.
METSYSTEM has a unique technology that can predict cancer metastasis and determine the best chemotherapy to treat it preventively.
Xterna is an engineering biology firm producing molecular binders that can identify certain cell types for medication delivery solutions.
Proxi Biotech develops a bacteria-resistant vaccine to treat multi-drug-resistant bacterial infections.
Akasi Pharma focuses on developing peptide-based therapeutics aimed at treating peripheral pain conditions.
NanoGuard Crop is a biotechnology company focused on developing next-generation, eco-friendly biopesticides for sustainable crop protection.
Fuse Vectors is disrupting the manufacturing process in order to provide universal access to gene therapy.
Incipiam Pharma focuses on developing innovative treatments for metabolic diseases by targeting energy expenditure.
MyoPax creates advanced regenerative stem cell therapies to combat the devasting effects of muscle illnesses.
TetraKit Technologies is a click chemistry-based radiochemical platform developing therapeutics for metastatic cancer.
Enduro Genetics is a technology provider committed to enabling large-scale fermentations.
BioInnovation Institute has invested in 157 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
BioInnovation Institute's top investment sectors include Biotechnology, Medical, Health Care, Therapeutics, Medical Device. The firm invests across 25 different industry categories.
Among tracked funding rounds, MATR Foods received $23.2M in a Series A round. BioInnovation Institute's total known invested capital is $402.9M.
BioInnovation Institute's average investment size is $3.6M across its portfolio of 157 companies.
Recent BioInnovation Institute portfolio additions include Microminer, SynuCa Therapeutics, CAMBIOTICS, HHC Medical, BOOST Pharma. These companies were founded in 2020 or later.